查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678723

腦腫瘤診斷與治療市場規模、佔有率、趨勢分析報告：按類型、產品、診斷、治療、最終用途、地區和細分市場預測，2025-2030 年

Brain Tumor Diagnosis And Therapeutics Market Size, Share & Trends Analysis Report By Type (Primary, Secondary), By Product, By Diagnosis (MRI, CT, PET-CT), By Therapeutics, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

腦腫瘤診斷和治療市場的成長和趨勢

預計到 2030 年全球腦瘤診斷和治療市場規模將達到 49.4 億美元，2025 年至 2030 年的複合年成長率為 7.3%。

由於各種腦瘤（尤其是膠質母細胞瘤）的發生率不斷增加，以及老年人口的增加，預計該市場在預測期內將出現良好的成長。

醫療保健領域官民合作關係(PPP) 的興起正在實現診斷成像和放射學服務的現代化，支持該行業的擴張。鈉磁振造影 (23Na MRI)、正子斷層掃描 (PET) 和化學交換飽和轉移 (CEST) 等新技術正在多中心臨床測試環境中用於檢測腦腫瘤反應。此外，這些技術可用於定量成像腫瘤對治療的反應，從而促進其在治療期間的使用。

這些技術有可能將 MRI 擴展到解剖成像之外，提供有關生理和細胞代謝的資訊，從而提高診斷效率。因此，預計市場在預測期內將見證生產成長。

此外，正在進行的分子診斷研究旨在從細胞層面了解惡性腫瘤的細胞生物學並識別與惡性腫瘤相關的基因突變，預計將對該產業的發展做出重大貢獻。

然而，腦瘤診斷的費用很高，從450美元到12,200美元不等，可能會阻礙全球腦瘤診斷市場的成長。

腦腫瘤診斷與治療市場報告重點

  • 診斷成像技術的進步極大地增強了市場的能力。
  • 領先細分市場將主導市場，到 2024 年將佔據 62.7% 的佔有率。
  • 著色劑和清漆將引領市場，到 2024 年的市佔率將達到 25.7%。
  • 電腦斷層掃描佔據市場主導地位，2024 年的收入佔有率為 25.8%。
  • 2024 年，外科手術佔最大佔有率，達 35.6%。
  • 2024 年腫瘤治療中心佔據最大的市場佔有率，為 48.5%。
  • 2024年北美腦腫瘤診斷與治療市場佔據全球市場主導地位，收益佔有率為41.9%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章腦腫瘤診斷與治療市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析 – 波特五力分析
    • PESTLE分析

第4章腦腫瘤診斷與治療市場：類型業務分析

  • 2024 年及 2030 年類型市場佔有率
  • 類型細分儀表板
  • 2018 年至 2030 年按類型分類的市場規模、預測與趨勢分析
  • 基本的
  • 次要

第5章腦腫瘤診斷與治療市場：產品業務分析

  • 2024 年及 2030 年產品市場佔有率
  • 產品細分儀表板
  • 2018 年至 2030 年按產品分類的市場規模、預測與趨勢分析
  • 染色劑和清漆
  • 蟲膠
  • 漆
  • 其他

第6章腦腫瘤診斷與治療市場：診斷業務分析

  • 2024 年和 2030 年診斷市場佔有率
  • 診斷細分儀表板
  • 市場規模、預測和趨勢分析（按診斷），2018 年至 2030 年
  • MRI
  • 電腦斷層掃描
  • 組織樣本採集
  • 正子電腦斷層掃描
  • 腦動脈造影
  • 腰椎穿刺
  • 分子檢測
  • 腦電圖
  • 其他

第7章腦腫瘤診斷與治療市場：治療業務分析

  • 2024 年和 2030 年治療市場佔有率
  • 治療細分儀表板
  • 2018 年至 2030 年按治療類型分類的市場規模、預測和趨勢分析
  • 外科手術
  • 放射治療
  • 化療
  • 免疫療法
  • 標靶治療
  • 其他

8. 腦腫瘤診斷與治療市場-最終用途業務分析

  • 2024 年及 2030 年終端用途市場佔有率
  • 最終用途細分儀表板
  • 2018 年至 2030 年按最終用途分類的市場規模、預測和趨勢分析
  • 醫院
  • 腫瘤中心
  • 其他

第9章腦腫瘤診斷和治療市場：按地區估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 按國家/地區，2018 年至 2030 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區，2018 年至 2030 年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 按國家/地區，2018 年至 2030 年
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區，2018 年至 2030 年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Amgen Inc.
    • AstraZeneca
    • Bayer Corporation
    • GE HealthCare
    • F. Hoffmann-La Roche Ltd
    • Eisai Co., Ltd.
    • Bristol-Myers Squibb Company
    • Pfizer Inc.
    • Shimadzu Corporation
    • Siemens Healthineers AG
Product Code: GVR-1-68038-349-2

Brain Tumor Diagnosis And Therapeutics Market Growth & Trends:

The global brain tumor diagnosis and therapeutics market size is expected to reach USD 4.94 billion in 2030 and is projected to grow at a CAGR of 7.3% from 2025 to 2030. The market is expected to pose lucrative growth over the forecast period, owing to the increasing incidence of various brain cancers, particularly glioblastoma, coupled with the rising geriatric population.

Increasing Public-Private Partnerships (PPPs) in the health sector, which are modernizing diagnostic imaging and radiology services, are supporting the expansion of this industry. Emerging technologies like Sodium Magnetic Resonance Imaging(23Na MRI), Positron Emission Tomography (PET), and Chemical Exchange Saturation Transfer (CEST) are used to detect the response of brain tumors in multicenter clinical trial settings. In addition, these technologies are helpful in quantitatively imaging tumor response to therapies, thereby promoting their use during treatment.

These technologies have the potential to extend MRI beyond anatomical imaging by providing information on physiology and cellular metabolism, thereby increasing the efficiency of diagnosis. Hence, the market is expected to witness productive growth over the forecast period.

Moreover, ongoing research in molecular diagnostics to understand cell biology at the cellular level of malignancy and identification of gene mutations associated with malignancy is anticipated to significantly contribute toward the growth of the industry.

On the other hand, the high cost of diagnosing brain tumors, which ranges from USD 450 to 12,200, is likely to hinder the growth of the global brain tumor diagnosis market.

Brain Tumor Diagnosis And Therapeutics Market Report Highlights:

  • Advancements in diagnostic imaging technologies have significantly enhanced the capabilities within the market
  • The primary segment dominated the market and accounted for a share of 62.7% in 2024
  • Stains & varnishes led the market and accounted for a share of 25.7% in 2024
  • CT scan dominated the market with a revenue share of 25.8% in 2024
  • Surgery held the largest market share of 35.6% in 2024
  • Oncology treatment centers held the largest market share of 48.5% in 2024
  • North America brain tumor diagnosis and therapeutics market dominated the global market with a revenue share of 41.9% in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Product
    • 1.2.3. Diagnosis
    • 1.2.4. Therapeutics
    • 1.2.5. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Brain Tumor Diagnosis and Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Brain Tumor Diagnosis and Therapeutics Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Primary
    • 4.4.1. Primary Market, 2018 - 2030 (USD Million)
    • 4.4.2. Meningioma
      • 4.4.2.1. Meningioma Market, 2018 - 2030 (USD Million)
    • 4.4.3. Gliomas
      • 4.4.3.1. Gliomas Market, 2018 - 2030 (USD Million)
    • 4.4.4. Astrocytomas
      • 4.4.4.1. Astrocytomas Market, 2018 - 2030 (USD Million)
    • 4.4.5. Pituitary Tumors
      • 4.4.5.1. Pituitary Tumors Market, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Secondary
    • 4.5.1. Secondary Market, 2018 - 2030 (USD Million)

Chapter 5. Brain Tumor Diagnosis and Therapeutics Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Stains & Varnishes
    • 5.4.1. Stains & Varnishes Market, 2018 - 2030 (USD Million)
  • 5.5. Shellacs
    • 5.5.1. Shellacs Market, 2018 - 2030 (USD Million)
  • 5.6. Lacquers
    • 5.6.1. Lacquers Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Brain Tumor Diagnosis and Therapeutics Market: Diagnosis Business Analysis

  • 6.1. Diagnosis Market Share, 2024 & 2030
  • 6.2. Diagnosis Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Diagnosis, 2018 to 2030 (USD Million)
  • 6.4. MRI
    • 6.4.1. MRI Market, 2018 - 2030 (USD Million)
  • 6.5. CT Scan
    • 6.5.1. CT Scan Market, 2018 - 2030 (USD Million)
  • 6.6. Tissue Sampling
    • 6.6.1. Tissue Sampling Market, 2018 - 2030 (USD Million)
  • 6.7. PET-CT scan
    • 6.7.1. PET-CT scan Market, 2018 - 2030 (USD Million)
  • 6.8. Cerebral Arteriogram
    • 6.8.1. Cerebral Arteriogram Market, 2018 - 2030 (USD Million)
  • 6.9. Lumbar Puncture
    • 6.9.1. Lumbar Puncture Market, 2018 - 2030 (USD Million)
  • 6.10. Molecular Testing
    • 6.10.1. Molecular Testing Market, 2018 - 2030 (USD Million)
  • 6.11. EEG
    • 6.11.1. EEG Market, 2018 - 2030 (USD Million)
  • 6.12. Others
    • 6.12.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Brain Tumor Diagnosis and Therapeutics Market: Therapeutics Business Analysis

  • 7.1. Therapeutics Market Share, 2024 & 2030
  • 7.2. Therapeutics Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Therapeutics, 2018 to 2030 (USD Million)
  • 7.4. Surgery
    • 7.4.1. Surgery Market, 2018 - 2030 (USD Million)
  • 7.5. Radiation Therapy
    • 7.5.1. Radiation Therapy Market, 2018 - 2030 (USD Million)
  • 7.6. Chemotherapy
    • 7.6.1. Chemotherapy Market, 2018 - 2030 (USD Million)
  • 7.7. Immunotherapy
    • 7.7.1. Immunotherapy Market, 2018 - 2030 (USD Million)
  • 7.8. Targeted Therapy
    • 7.8.1. Targeted Therapy Market, 2018 - 2030 (USD Million)
  • 7.9. Others
    • 7.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Brain Tumor Diagnosis and Therapeutics Market: End Use Business Analysis

  • 8.1. End Use Market Share, 2024 & 2030
  • 8.2. End Use Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Hospitals
    • 8.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 8.5. Oncology Treatment Centers
    • 8.5.1. Oncology Treatment Centers Market, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Brain Tumor Diagnosis and Therapeutics Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Framework
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. U.S. Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Framework
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Canada Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Framework
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. Mexico Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Framework
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. UK Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Framework
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Germany Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Framework
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. France Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Regulatory Framework
      • 9.5.5.3. Competitive Insights
      • 9.5.5.4. Italy Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Regulatory Framework
      • 9.5.6.3. Competitive Insights
      • 9.5.6.4. Spain Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Regulatory Framework
      • 9.5.7.3. Competitive Insights
      • 9.5.7.4. Norway Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.8. Denmark
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Regulatory Framework
      • 9.5.8.3. Competitive Insights
      • 9.5.8.4. Denmark Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.9. Sweden
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Regulatory Framework
      • 9.5.9.3. Competitive Insights
      • 9.5.9.4. Sweden Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Framework
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Japan Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Framework
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. China Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Framework
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. India Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. South Korea
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Framework
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. South Korea Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. Australia
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Regulatory Framework
      • 9.6.6.3. Competitive Insights
      • 9.6.6.4. Australia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Regulatory Framework
      • 9.6.7.3. Competitive Insights
      • 9.6.7.4. Thailand Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Regulatory Framework
      • 9.7.2.3. Competitive Insights
      • 9.7.2.4. Brazil Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Regulatory Framework
      • 9.7.3.3. Competitive Insights
      • 9.7.3.4. Argentina Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Regulatory Framework
      • 9.8.2.3. Competitive Insights
      • 9.8.2.4. South Africa Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Regulatory Framework
      • 9.8.3.3. Competitive Insights
      • 9.8.3.4. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Regulatory Framework
      • 9.8.4.3. Competitive Insights
      • 9.8.4.4. UAE Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Regulatory Framework
      • 9.8.5.3. Competitive Insights
      • 9.8.5.4. Kuwait Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis
  • 10.3. Company Categorization
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles/Listing
    • 10.5.1. Amgen Inc.
      • 10.5.1.1. Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Strategic Initiatives
    • 10.5.2. AstraZeneca
      • 10.5.2.1. Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Strategic Initiatives
    • 10.5.3. Bayer Corporation
      • 10.5.3.1. Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Strategic Initiatives
    • 10.5.4. GE HealthCare
      • 10.5.4.1. Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Strategic Initiatives
    • 10.5.5. F. Hoffmann-La Roche Ltd
      • 10.5.5.1. Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Strategic Initiatives
    • 10.5.6. Eisai Co., Ltd.
      • 10.5.6.1. Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Strategic Initiatives
    • 10.5.7. Bristol-Myers Squibb Company
      • 10.5.7.1. Overview
      • 10.5.7.2. Financial Performance
      • 10.5.7.3. Product Benchmarking
      • 10.5.7.4. Strategic Initiatives
    • 10.5.8. Pfizer Inc.
      • 10.5.8.1. Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Strategic Initiatives
    • 10.5.9. Shimadzu Corporation
      • 10.5.9.1. Overview
      • 10.5.9.2. Financial Performance
      • 10.5.9.3. Product Benchmarking
      • 10.5.9.4. Strategic Initiatives
    • 10.5.10. Siemens Healthineers AG
      • 10.5.10.1. Overview
      • 10.5.10.2. Financial Performance
      • 10.5.10.3. Product Benchmarking
      • 10.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global brain tumor diagnosis and therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 6 Global brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 7 Global brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 8 Global brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 North America brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 11 North America brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 12 North America brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 13 North America brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 14 North America brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 15 U.S. brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 16 U.S. brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 17 U.S. brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 18 U.S. brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 19 U.S. brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Canada brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Canada brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Canada brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 23 Canada brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 24 Canada brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Europe brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 26 Mexico brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Mexico brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 28 Mexico brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 29 Mexico brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 30 Mexico brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Europe brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Europe brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 33 Europe brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 34 Europe brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 35 Europe brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 36 UK brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 37 UK brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 38 UK brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 39 UK brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 40 UK brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Germany brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 42 Germany brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 43 Germany brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 44 Germany brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 45 Germany brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 46 France brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 47 France brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 48 France brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 49 France brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 50 France brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Italy brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 52 Italy brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 53 Italy brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 54 Italy brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 55 Italy brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Spain brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 57 Spain brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Spain brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 59 Spain brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 60 Spain brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Denmark brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 62 Denmark brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Denmark brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 64 Denmark brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 65 Denmark brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Sweden brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 67 Sweden brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 68 Sweden brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 69 Sweden brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 70 Sweden brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Norway brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 72 Norway brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 73 Norway brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 74 Norway brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 75 Norway brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 82 China brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 83 China brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 84 China brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 85 China brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 86 China brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Japan brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 88 Japan brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 89 Japan brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 90 Japan brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 91 Japan brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 92 India brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 93 India brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 94 India brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 95 India brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 96 India brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Australia brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 98 Australia brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 99 Australia brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 100 Australia brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 101 Australia brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 102 South Korea brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 103 South Korea brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 104 South Korea brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 105 South Korea brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 106 South Korea brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Thailand brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 108 Thailand brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 109 Thailand brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 110 Thailand brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 111 Thailand brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Latin America brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 113 Latin America brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 114 Latin America brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 115 Latin America brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 116 Latin America brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 117 Latin America brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 118 Brazil brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 119 Brazil brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 120 Brazil brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 121 Brazil brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 122 Brazil brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 123 Argentina brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 124 Argentina brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 125 Argentina brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 126 Argentina brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 127 Argentina brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 134 South Africa brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 135 South Africa brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 136 South Africa brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 137 South Africa brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 138 South Africa brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 144 UAE brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 145 UAE brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 146 UAE brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 147 UAE brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 148 UAE brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 150 Kuwait brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 151 Kuwait brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 152 Kuwait brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 153 Kuwait brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Brain tumor diagnosis and therapeutics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and product outlook (USD Million)
  • Fig. 10 Diagnosis and therapeutics outlook (USD Million)
  • Fig. 11 End use outlook (USD Million)
  • Fig. 12 Competitive landscape
  • Fig. 13 Brain tumor diagnosis and therapeutics market dynamics
  • Fig. 14 Brain tumor diagnosis and therapeutics market: Porter's five forces analysis
  • Fig. 15 Brain tumor diagnosis and therapeutics market: PESTLE analysis
  • Fig. 16 Brain tumor diagnosis and therapeutics market: Type segment dashboard
  • Fig. 17 Brain tumor diagnosis and therapeutics market: Type market share analysis, 2024 & 2030
  • Fig. 18 Primary market, 2018 - 2030 (USD Million)
  • Fig. 19 Meningioma market, 2018 - 2030 (USD Million)
  • Fig. 20 Gliomas market, 2018 - 2030 (USD Million)
  • Fig. 21 Astrocytomas market, 2018 - 2030 (USD Million)
  • Fig. 22 Pituitary tumors market, 2018 - 2030 (USD Million)
  • Fig. 23 Others market, 2018 - 2030 (USD Million)
  • Fig. 24 Secondary market, 2018 - 2030 (USD Million)
  • Fig. 25 Brain tumor diagnosis and therapeutics market: Product segment dashboard
  • Fig. 26 Brain tumor diagnosis and therapeutics market: Product market share analysis, 2024 & 2030
  • Fig. 27 Stains & varnishes market, 2018 - 2030 (USD Million)
  • Fig. 28 Shellacs market, 2018 - 2030 (USD Million)
  • Fig. 29 Lacquers market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Brain tumor diagnosis and therapeutics market: Diagnosis segment dashboard
  • Fig. 32 Brain tumor diagnosis and therapeutics market: Diagnosis market share analysis, 2024 & 2030
  • Fig. 33 MRI market, 2018 - 2030 (USD Million)
  • Fig. 34 CT scan market, 2018 - 2030 (USD Million)
  • Fig. 35 Tissue sampling market, 2018 - 2030 (USD Million)
  • Fig. 36 PET-CT scan market, 2018 - 2030 (USD Million)
  • Fig. 37 Cerebral arteriogram market, 2018 - 2030 (USD Million)
  • Fig. 38 Lumbar puncture market, 2018 - 2030 (USD Million)
  • Fig. 39 Molecular testing market, 2018 - 2030 (USD Million)
  • Fig. 40 EEG market, 2018 - 2030 (USD Million)
  • Fig. 41 Others market, 2018 - 2030 (USD Million)
  • Fig. 42 Brain tumor diagnosis and therapeutics market: Therapeutics segment dashboard
  • Fig. 43 Brain tumor diagnosis and therapeutics market: Therapeutics market share analysis, 2024 & 2030
  • Fig. 44 Surgery market, 2018 - 2030 (USD Million)
  • Fig. 45 Radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 46 Chemotherapy market, 2018 - 2030 (USD Million)
  • Fig. 47 Immunotherapy market, 2018 - 2030 (USD Million)
  • Fig. 48 Targeted therapy market, 2018 - 2030 (USD Million)
  • Fig. 49 Others market, 2018 - 2030 (USD Million)
  • Fig. 50 Brain tumor diagnosis and therapeutics market: End use segment dashboard
  • Fig. 51 Brain tumor diagnosis and therapeutics market: End use market share analysis, 2024 & 2030
  • Fig. 52 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 53 Oncology treatment centers market, 2018 - 2030 (USD Million)
  • Fig. 54 Others market, 2018 - 2030 (USD Million)
  • Fig. 55 Brain tumor diagnosis and therapeutics market revenue, by region
  • Fig. 56 Regional marketplace: Key takeaways
  • Fig. 57 Regional marketplace: Key takeaways
  • Fig. 58 North America brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 59 U.S. country dynamics
  • Fig. 60 U.S. brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 61 Canada country dynamics
  • Fig. 62 Canada brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico country dynamics
  • Fig. 64 Mexico brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 65 Europe brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 66 UK country dynamics
  • Fig. 67 UK brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 68 Germany country dynamics
  • Fig. 69 Germany brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 70 France country dynamics
  • Fig. 71 France brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 72 Italy country dynamics
  • Fig. 73 Italy brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 74 Spain country dynamics
  • Fig. 75 Spain brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 76 Norway country dynamics
  • Fig. 77 Norway brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 78 Sweden country dynamics
  • Fig. 79 Sweden brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 80 Denmark country dynamics
  • Fig. 81 Denmark brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 82 Asia Pacific brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 83 Japan country dynamics
  • Fig. 84 Japan brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 85 China country dynamics
  • Fig. 86 China brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 87 India country dynamics
  • Fig. 88 India brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 89 Australia country dynamics
  • Fig. 90 Australia brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 91 South Korea country dynamics
  • Fig. 92 South Korea brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 93 Thailand country dynamics
  • Fig. 94 Thailand brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 95 Latin America brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 96 Brazil country dynamics
  • Fig. 97 Brazil brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 98 Argentina country dynamics
  • Fig. 99 Argentina brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 100 MEA brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 101 South Africa country dynamics
  • Fig. 102 South Africa brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 103 Saudi Arabia country dynamics
  • Fig. 104 Saudi Arabia brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 105 UAE country dynamics
  • Fig. 106 UAE brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 107 Kuwait country dynamics
  • Fig. 108 Kuwait brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 109 Company categorization
  • Fig. 110 Company market position analysis
  • Fig. 111 Strategic framework